Form 483

TriRx Segre Form 483, 2012-06-15

FDA issued a Form 483 to TriRx Segre on 2012-06-15 with 4 public-safe observations.

483· Form 483 issued4 observations

TriRx Segre · Segre-En-Anjou Bleu, France · Issued June 15, 2012

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Jun 2012
21 CFR 211.42(c)(10)(iii)

Air Supply

Cited by Robert J Martin, Barbara D Paul

15 Jun 2012
21 CFR 211.44

Adequate lighting not provided

Cited by Robert J Martin, Barbara D Paul

15 Jun 2012
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Robert J Martin, Barbara D Paul

15 Jun 2012
21 CFR 211.165(e)

Test methods

Cited by Robert J Martin, Barbara D Paul

Inspected site

TSTriRx SegreSegre-En-Anjou Bleu, France

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations1x
21 CFR 211.44Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere